TNFRSF10B and malignant colon neoplasm: However, the contribution of TRAIL-R2 to colorectal tumour growth and apoptosis sensitivity has recently been demonstrated by Wang and El-Deiry (2004) using stable human colon cancer cell lines in which the function of TRAIL-R2 was ablated using inducible RNA interference in a mouse xenograft model.